These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28412379)

  • 1. Challenges of measles and rubella laboratory diagnostic in the era of elimination.
    Hübschen JM; Bork SM; Brown KE; Mankertz A; Santibanez S; Ben Mamou M; Mulders MN; Muller CP
    Clin Microbiol Infect; 2017 Aug; 23(8):511-515. PubMed ID: 28412379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of the global measles and rubella laboratory network 2005-09.
    Featherstone DA; Rota PA; Icenogle J; Mulders MN; Jee Y; Ahmed H; de Filippis AM; Ramamurty N; Gavrilin E; Byabamazima C; Dosseh A; Xu W; Komase K; Tashiro M; Brown D; Bellini WJ; Strebel P
    J Infect Dis; 2011 Jul; 204 Suppl 1():S491-8. PubMed ID: 21666205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of serological and molecular analyses for the diagnosis of measles cases and for meeting elimination targets in Turkey from 2007 to 2015.
    Cosgun Y; Guldemir D; Coskun A; Yolbakan S; Kalaycioglu AT; Korukluoglu G; Durmaz R
    Epidemiol Infect; 2018 Apr; 146(6):735-740. PubMed ID: 29534775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular surveillance of measles and rubella in the WHO European Region: new challenges in the elimination phase.
    Santibanez S; Hübschen JM; Ben Mamou MC; Muscat M; Brown KE; Myers R; Donoso Mantke O; Zeichhardt H; Brockmann D; Shulga SV; Muller CP; O'Connor PM; Mulders MN; Mankertz A
    Clin Microbiol Infect; 2017 Aug; 23(8):516-523. PubMed ID: 28712666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of measles, mumps, and rubella viruses.
    Tipples G; Hiebert J
    Methods Mol Biol; 2011; 665():183-93. PubMed ID: 21116802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a rapid digital microfluidics-powered immunoassay for assessing measles and rubella infection and immunity in outbreak settings in the Democratic Republic of the Congo.
    Knipes AK; Summers A; Sklavounos AA; Lamanna J; de Campos RPS; Narahari T; Dixon C; Fobel R; Ndjakani YD; Lubula L; Magazani A; Muyembe JJ; Lay Y; Pukuta E; Waku-Kouomou D; Hao L; Kayembe JK; Fobel C; Dahmer J; Lee A; Ho M; Valenzuela JGC; Rackus DG; Shih R; Seale B; Chang A; Paluku G; Rota PA; Wheeler AR; Scobie HM
    PLoS One; 2022; 17(12):e0278749. PubMed ID: 36542608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations from an ad hoc Meeting of the WHO Measles and Rubella Laboratory Network (LabNet) on use of alternative diagnostic samples for measles and rubella surveillance.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Jun; 57(24):657-60. PubMed ID: 18566565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles and rubella elimination in the WHO Region for Europe: progress and challenges.
    O'Connor P; Jankovic D; Muscat M; Ben-Mamou M; Reef S; Papania M; Singh S; Kaloumenos T; Butler R; Datta S
    Clin Microbiol Infect; 2017 Aug; 23(8):504-510. PubMed ID: 28111293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of measles and rubella IgM serology in an elimination setting, Ontario, Canada, 2009-2014.
    Bolotin S; Lim G; Dang V; Crowcroft N; Gubbay J; Mazzulli T; Schabas R
    PLoS One; 2017; 12(8):e0181172. PubMed ID: 28850604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Characterization of Measles and Rubella Viruses Detected Through Global Measles and Rubella Elimination Surveillance, 2016-2018.
    Brown KE; Rota PA; Goodson JL; Williams D; Abernathy E; Takeda M; Mulders MN
    MMWR Morb Mortal Wkly Rep; 2019 Jul; 68(26):587-591. PubMed ID: 31269012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The State of Measles and Rubella in the WHO European region.
    Muscat M; Ben Mamou M; Shefer A; Jankovic D; Deshevoy S; Butler R
    Rev Esp Salud Publica; 2015; 89(4):345-51. PubMed ID: 26580789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global landscape of measles and rubella surveillance.
    Patel MK; Gibson R; Cohen A; Dumolard L; Gacic-Dobo M
    Vaccine; 2018 Nov; 36(48):7385-7392. PubMed ID: 30318167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory confirmation of rubella infection in suspected measles cases.
    Vaidya SR; Raut CG; Jadhav SM
    J Med Virol; 2016 Oct; 88(10):1685-9. PubMed ID: 27018071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards elimination of measles and rubella in Italy: Progress and challenges.
    Adamo G; Baccolini V; Massimi A; Barbato D; Cocchiara R; Di Paolo C; Mele A; Cianfanelli S; Angelozzi A; Castellani F; Salerno C; Isonne C; Bella A; Filia A; Del Manso M; Baggieri M; Nicoletti L; Magurano F; Iannazzo S; Marzuillo C; Villari P
    PLoS One; 2019; 14(12):e0226513. PubMed ID: 31841530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic algorithm for the confirmation of cases of measles and rubella in Mexico.
    Román-Pedroza JF; Cruz-Ramírez E; Landín-Martínez KE; Salas-García M; López-Ortiz E; Ramírez-González JE; López-Martínez I; Díaz-Quiñonez JA
    Gac Med Mex; 2019; 155(5):492-495. PubMed ID: 32091024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global Measles and Rubella Laboratory Network Support for Elimination Goals, 2010-2015.
    Mulders MN; Rota PA; Icenogle JP; Brown KE; Takeda M; Rey GJ; Ben Mamou MC; Dosseh AR; Byabamazima CR; Ahmed HJ; Pattamadilok S; Zhang Y; Gacic-Dobo M; Strebel PM; Goodson JL
    MMWR Morb Mortal Wkly Rep; 2016 May; 65(17):438-42. PubMed ID: 27148917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monitoring of implementation of international programs of poliomyelitis eradication and measles and rubella elimination in the Republic of Belarus].
    Zh Mikrobiol Epidemiol Immunobiol; 2012; (1):21-30. PubMed ID: 22442967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous IgM reactivity by EIA against more than one virus in measles, parvovirus B19 and rubella infection.
    Thomas HI; Barrett E; Hesketh LM; Wynne A; Morgan-Capner P
    J Clin Virol; 1999 Oct; 14(2):107-18. PubMed ID: 10588453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential diagnosis of fever and rash cases negative for measles and rubella to complement surveillance activities.
    Fappani C; Gori M; Bianchi S; Terraneo M; Bilardi E; Colzani D; Tanzi E; Canuti M; Amendola A
    J Med Virol; 2023 Oct; 95(10):e29141. PubMed ID: 37796084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in the elimination of measles and rubella in the WHO European Region].
    Muscat M; Jankovic D; Goel A; Butler R; Pfeifer D
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1225-30. PubMed ID: 23990083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.